| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033619 |
| Receipt No. | R000038336 |
| Scientific Title | A study for the effect of intake of food derived from microorganism on eye strain |
| Date of disclosure of the study information | 2020/05/31 |
| Last modified on | 2020/06/29 (Ver. 2) |
| Basic information | ||
| Public title | A study for the effect of intake of food derived from microorganism on eye strain | |
| Acronym | A study for the effect of intake of food derived from microorganism on eye strain | |
| Scientific Title | A study for the effect of intake of food derived from microorganism on eye strain | |
| Scientific Title:Acronym | A study for the effect of intake of food derived from microorganism on eye strain | |
| Region |
|
|
| Condition | ||
| Condition | None (Healthy adults) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect of intake of food derived from microorganism on eye strain |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Tests for eye strain |
| Key secondary outcomes | Questionnaires |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Capsule containing food derived from microorganism, once a day for 8 weeks | |
| Interventions/Control_2 | Capsule not containing food derived from microorganism, once a day for 8 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Healthy Japanese men and women aged from 35 to less than 50 years old
(2) Subjects with subjective eye strain (3) Subjects who are judged as suitable for this study by the investigator |
|||
| Key exclusion criteria | (1) Subjects who are under treatment of or have history of cancer, heart failure and myocardial infarction
(2) Subjects who are under treatment of or have history of chronic diseases (3) Subjects who are diagnosed with or aware of presbyopia (4) Subjects who have eye disease (5) Subjects who are diagnosed with asthenopia (6) Subjects who use eye drops for eye disease (7) Subjects who have an uncorrected serious refractive error (8) Subjects who had LASIK surgery (9) Subjects who have serious astigmatism (10) Subjects who have amblyopia or strabismus (11) Subjects whose best-corrected visual acuity is < 1.0 (12) Subjects who are diagnosed with eye strain caused by anything except for neurogenic or adjust function (13) Subjects who work in a company developing functional foods (14) Subjects with excessive alcohol-drinking (15) Subjects who can't stop drinking alcohol for 2 days until the check days (16) Subjects who usually take or will take drugs or health foods for eye (17) Subjects who can't stop take drugs or health foods for regulation of immune functions (18) Subjects who can't stop eating foods similar to the test foods and/or can't stop taking drugs or health foods including lactic acid bacteria or Bifidobacterium (19) Subjects who have tendency to get diarrhea by eating dairy products (20) Subjects who have risk to develop allergy caused by foods or drugs (21) Subjects who have drug dependence or allergy dependence (22) Subjects who are diagnosed with hay fever (23) Subjects who can't complete workload for eye strain (24) Subjects who are not suitable for this study by results of lifestyle questionnaire (25) Subjects who are or are planning to be pregnant or breastfeeding during this study (26) Subjects who participated in other clinical trial within 3 months prior to obtaining informed consent, or are planning to participate other clinical trial (27) Subjects who are judged as unsuitable for participating this study by the investigator |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kirin Company, Limited | ||||||
| Division name | Research Laboratories for Health Science & Food Technologies, Research & Development Division | ||||||
| Zip code | |||||||
| Address | 1-13-5, Fukuura Kanazawa-ku, Yokohama, Kanagawa Japan | ||||||
| TEL | 045-788-7200 | ||||||
| Yuji_Morita@kirin.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | ORTHOMEDICO Inc. | ||||||
| Division name | R&D Department | ||||||
| Zip code | |||||||
| Address | 2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan | ||||||
| TEL | 03-3818-0610 | ||||||
| Homepage URL | |||||||
| nao@orthomedico.jp | |||||||
| Sponsor | |
| Institute | ORTHOMEDICO Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kirin Company, Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | アリオ西新井クリニック眼科(東京) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038336 |